Cite

HARVARD Citation

    Baraliakos, X. et al. (2016). Long-term efficiency of infliximab in patients with ankylosing spondylitis: real life data confirm the potential for dose reduction. RMD open. 2 (2), p. . [Online]. 
  
Back to record